BioAegis gets Spanish approval for Phase II Covid-19 trial of gelsolin
US-based BioAegis Therapeutics has received approval from the Spanish Agency for Medicines and Health Products...
COVID-19 coronavirus: Top ten most-affected countries
One Asian country and seven European countries are among the ten most affected list of...
SOM Biotech
SOM Biotech is an Artificial Intelligence AI drug discovery and development company focused on the...
DR Healthcare
DR Healthcare specialises in the research, development and certification of nutraceuticals and functional foods, as...
Laboratorios Planes (PLANtas ESpañolas)
Laboratorios Planes is a modern laboratory that manufactures herb-based and natural food supplements for the...
Sofpromed to use TrialMaster EDC for oncology clinical trials
Spain-based contract research organisation (CRO) Sofpromed has selected TrialMaster as its preferred electronic data capture...
ESMO 2019: BeiGene presents data on tislelizumab and pamiparib
Biopharmaceutical company BeiGene has presented data on its two investigational drug candidates, anti-PD-1 antibody tislelizumab...
Oryzon’s vafidemstat yields positive results in autism patients
Spanish biopharmaceutical firm Oryzon Genomics has reported that vafidemstat led to improvements in aggressive behaviour...
Oryzon closes enrolment in vafidemstat’s Phase IIa trials
Spain-based Oryzon Genomics has completed patient enrolment in the Phase IIa REIMAGINE and REIMAGINE-AD clinical...
Grifols reports positive data from Alzheimer’s study AMBAR
Spanish healthcare company Grifols has reported new results from its Alzheimer Management by Albumin Replacement...